Global X HealthTech ETF (HEAL)
| Assets | $25.69M |
| Expense Ratio | 0.50% |
| PE Ratio | 27.95 |
| Shares Out | 999,868 |
| Dividend (ttm) | $0.10 |
| Dividend Yield | 0.38% |
| Ex-Dividend Date | Dec 30, 2025 |
| Payout Ratio | 10.55% |
| 1-Year Return | -9.91% |
| Volume | 1,761 |
| Open | 25.53 |
| Previous Close | 25.65 |
| Day's Range | 25.43 - 25.83 |
| 52-Week Low | 23.00 |
| 52-Week High | 34.20 |
| Beta | 1.17 |
| Holdings | 43 |
| Inception Date | Jul 29, 2020 |
About HEAL
Fund Home PageThe Global X HealthTech ETF (HEAL) is an exchange-traded fund that is based on the Global X HealthTech index. The fund tracks a narrow index of stocks globally, seeking to capture novel applications of AI technology and robotics focused on the healthcare industry. Companies selected must derive 50% of their revenue from one of the four subthemes HEAL was launched on Jul 29, 2020 and is issued by Global X.
Top 10 Holdings
44.68% of assets| Name | Symbol | Weight |
|---|---|---|
| Masimo Corporation | MASI | 5.93% |
| DexCom, Inc. | DXCM | 5.41% |
| Koninklijke Philips N.V. | PHIA | 4.70% |
| GE HealthCare Technologies Inc. | GEHC | 4.55% |
| TransMedics Group, Inc. | TMDX | 4.51% |
| ResMed Inc. | RMD | 4.16% |
| Intuitive Surgical, Inc. | ISRG | 4.04% |
| Alignment Healthcare, Inc. | ALHC | 3.93% |
| Alibaba Health Information Technology Limited | 0241 | 3.84% |
| IQVIA Holdings Inc. | IQV | 3.62% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.07184 | Jan 7, 2026 |
| Jun 27, 2025 | $0.02446 | Jul 7, 2025 |
| Dec 30, 2020 | $0.01927 | Jan 8, 2021 |
News
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs
The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.
Global X Announces Five ETF Reverse Stock Splits
NEW YORK, Aug. 18, 2025 /PRNewswire/ -- Global X Management Company, LLC ("Global X"), the New York-based provider of exchange traded funds (ETFs), today announced reverse splits of the following five...
7 Megatrend Stock ETFs With Massive Potential
In 2022, the U.S. equities market got off to its worst start to a year since the dark days of the financial crisis, with many areas of the market, including stocks and stock exchange-traded funds (ETF...
These are Global X's most popular thematic ETFs this year
Global X ETFs vice president and head of research and strategy Jay Jacobs runs through his firm's fastest-growing ETFs this year. With CNBC's Bob Pisani.
3 New ETFs For 2021: Rookies Ready To Come Of Age
Rarely is it a dull year in the exchange traded funds industry and 2020 was no exception. Among the many records set last year in ETF Land were closures and launches.
Real Reasons This New ETF's Success Is Credible
Among new exchange-traded funds, there are always winners and losers on asset gathering. Then there are outright legends.
This Hot New ETF Will Be Just Fine After COVID-19 Is Defeated
Plenty of new exchange-traded funds are coming to market this year and many have something in common: Leverage to the coronavirus pandemic. What To Know: That's been a boon for many of these rookie fu...
The Doctor Is In With This New Telemedicine ETF
Telemedicine was in the early innings of a boom prior to the coronavirus pandemic, but the pandemic hastened the industry's ascent, as it has with several other market segments.